|
10 Companies |
|
6 Products |
|
6 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
63 News |
|
| 12» |
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: The Pilot Study of Chikungunya Virus Infections in Southern Taiwan (clinicaltrials.gov) - Mar 1, 2019
P=N/A, N=28, Completed, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Recruiting --> Completed | N=300 --> 28 | Trial completion date: Dec 2018 --> Jul 2018 | Trial primary completion date: Dec 2018 --> Jul 2018
- | TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - May 3, 2018
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting --> Completed | N=300 --> 28 | Trial completion date: Dec 2018 --> Jul 2018 | Trial primary completion date: Dec 2018 --> Jul 2018 Trial completion date: Feb 2018 --> Sep 2018
- | Phase classification: Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia (clinicaltrials.gov) - Jan 16, 2018
P=N/A, N=1500, Completed, Sponsor: Sanofi
Trial completion date: Feb 2018 --> Sep 2018 Phase classification: P2 --> P=N/A
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Oct 12, 2017
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Phase classification: P2 --> P=N/A Trial primary completion date: Nov 2017 --> Jul 2015
- ||| TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial completion, Trial primary completion date: DPIV-002: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (clinicaltrials.gov) - May 23, 2017
P1, N=100, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Nov 2017 --> Jul 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jan 2017
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-002: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (clinicaltrials.gov) - May 3, 2017
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jan 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Apr 7, 2017
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Nov 2016 --> Nov 2017
- | Trial completion, Enrollment change: Pilot Survey of Dengue Fever in Solomon Islands (clinicaltrials.gov) - Mar 7, 2017
P=N/A, N=2200, Completed, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Trial primary completion date: Nov 2016 --> Nov 2017 Recruiting --> Completed | N=1400 --> 2200
- Trial completion: IDAMS: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=7411, Completed, Sponsor: University of Heidelberg Medical Center
Recruiting --> Completed | N=1400 --> 2200 Recruiting --> Completed
- Trial completion, Enrollment change: Laboratory Diagnosis and Prognosis of Severe Dengue (clinicaltrials.gov) - Sep 30, 2016
P=N/A, N=8100, Completed, Sponsor: Oxford University Clinical Research Unit, Vietnam
Recruiting --> Completed Recruiting --> Completed | N=13500 --> 8100
- Trial primary completion date: The Pilot Study of Chikungunya Virus Infections in Southern Taiwan (clinicaltrials.gov) - Jun 23, 2016
P=N/A, N=300, Recruiting, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Recruiting --> Completed | N=13500 --> 8100 Trial primary completion date: Dec 2015 --> Dec 2018
- ||| WRAIR GSK TDEN vaccine / GSK, U.S. Army Medical Research and Development Command
Trial initiation date: A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children (clinicaltrials.gov) - Mar 1, 2016
P2, N=636, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Dec 2015 --> Dec 2018 Initiation date: Apr 2007 --> Jul 2007
- Enrollment change, Trial primary completion date: IDAMS: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=7500, Recruiting, Sponsor: University of Heidelberg Medical Center
Initiation date: Apr 2007 --> Jul 2007 N=10000 --> 7500 | Trial primary completion date: Dec 2015 --> Jun 2016
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Nov 10, 2015
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
N=10000 --> 7500 | Trial primary completion date: Dec 2015 --> Jun 2016 Trial primary completion date: Nov 2015 --> Nov 2016
- Trial completion, Enrollment change: ADEPT: Adult Dengue Platelet Study (clinicaltrials.gov) - Aug 25, 2015
P=N/A, N=372, Completed, Sponsor: Tan Tock Seng Hospital
Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=800 --> 372
- TV003 / Medigen Biotech, National Institute of Allergy and Infectious Diseases, TV005 / National Institute of Allergy and Infectious Diseases
Trial completion, IO biomarker: Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (clinicaltrials.gov) - Aug 20, 2015
P1, N=112, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed | N=800 --> 372 Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal: Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=0, Withdrawn, Sponsor: University of Massachusetts, Worcester
Active, not recruiting --> Completed N=245 --> 0 | Not yet recruiting --> Withdrawn
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Apr 25, 2015
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
N=245 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Oct 2014 --> Nov 2015
- Trial completion: Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease (clinicaltrials.gov) - Apr 22, 2015
P1, N=20, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Oct 2014 --> Nov 2015 Active, not recruiting --> Completed
- | tetravalent dengue vaccine (TVDV) / Fresh Tracks Therap, U.S. Army Medical Research and Development Command
Trial completion: TVDV: Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease (clinicaltrials.gov) - Apr 22, 2015
P1, N=40, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Pilot Survey of Dengue Fever in Solomon Islands (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=1400, Recruiting, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Active, not recruiting --> Completed Trial primary completion date: Dec 2014 --> Dec 2016
- Enrollment change: Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection (clinicaltrials.gov) - Apr 3, 2015
P=N/A, N=0, Withdrawn, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Trial primary completion date: Dec 2014 --> Dec 2016 N=450 --> 0
- Trial primary completion date: IDAMS: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (clinicaltrials.gov) - Jan 26, 2015
P=N/A, N=10000, Recruiting, Sponsor: University of Heidelberg Medical Center
N=450 --> 0 Trial primary completion date: May 2015 --> Dec 2015
- Trial primary completion date: IDAMS: International Research Consortium on Dengue Risk Assessment, Management, and Surveillance (clinicaltrials.gov) - Dec 9, 2014
P=N/A, N=10000, Recruiting, Sponsor: University of Heidelberg Medical Center
Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Oct 2015 --> May 2015
- Trial initiation date: Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=245, Not yet recruiting, Sponsor: University of Massachusetts, Worcester
Trial primary completion date: Oct 2015 --> May 2015 Initiation date: Jun 2014 --> Jan 2015
- Trial primary completion date: Laboratory Diagnosis and Prognosis of Severe Dengue (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=13500, Recruiting, Sponsor: Oxford University Clinical Research Unit, Vietnam
Initiation date: Jun 2014 --> Jan 2015 Trial primary completion date: Nov 2013 --> Dec 2014
- Clinical: The Pilot Study of Chikungunya Virus Infections in Southern Taiwan (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=300, Recruiting, Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
- || TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial primary completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - May 18, 2014
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Nov 2013 --> Dec 2014 Trial primary completion date: Jun 2013 --> Oct 2014
- | TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Trial completion date: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - May 18, 2014
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Trial primary completion date: Jun 2013 --> Oct 2014 Trial completion date: Dec 2013 --> Feb 2015
- Trial primary completion date: ADEPT: Adult Dengue Platelet Study (clinicaltrials.gov) - May 4, 2014
P=N/A, N=800, Recruiting, Sponsor: Tan Tock Seng Hospital
Trial completion date: Dec 2013 --> Feb 2015 Trial primary completion date: Jun 2013 --> Dec 2014
- Trial completion date: ADEPT: Adult Dengue Platelet Study (clinicaltrials.gov) - May 4, 2014
P=N/A, N=800, Recruiting, Sponsor: Tan Tock Seng Hospital
Trial primary completion date: Jun 2013 --> Dec 2014 Trial completion date: Jun 2013 --> Dec 2014
- || Enrollment change: Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children (clinicaltrials.gov) - Apr 24, 2014
P=N/A, N=667, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Trial completion date: Jun 2013 --> Dec 2014 N=2614 --> 667
- ||| Trial completion: Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children (clinicaltrials.gov) - Apr 24, 2014
P=N/A, N=667, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
N=2614 --> 667 Active, not recruiting --> Completed
- TV003 / Medigen Biotech, National Institute of Allergy and Infectious Diseases, TV005 / National Institute of Allergy and Infectious Diseases
Enrollment closed, IO biomarker: Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (clinicaltrials.gov) - Feb 27, 2014
P1, N=112, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Enrollment closed: DPIV-002: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (clinicaltrials.gov) - Feb 23, 2014
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial completion: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P1, N=28, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P1, N=28, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed No longer recruiting --> Completed
- Enrollment change: A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Na (clinicaltrials.gov) - Jan 9, 2014
P1/2, N=7, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
No longer recruiting --> Completed N=10 --> 7
- BuCast (celgosivir) / BioWest Therap
Trial completion: CELADEN: Celgosivir as a Treatment Against Dengue (clinicaltrials.gov) - Nov 27, 2013
P1/2, N=50, Completed, Sponsor: Singapore General Hospital
N=10 --> 7 Active, not recruiting --> Completed
- Trial completion, IO biomarker: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy Adults (clinicaltrials.gov) - Nov 12, 2013
P1, N=56, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Qdenga (dengue tetravalent vaccine [live, attenuated]) / Takeda
Trial completion: Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever (clinicaltrials.gov) - Oct 13, 2013
P1, N=96, Completed, Sponsor: Inviragen Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
Enrollment closed: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Jun 2, 2013
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Dengvaxia (Dengue vaccine) / Sanofi
Trial completion: A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines (clinicaltrials.gov) - Feb 4, 2013
P2, N=210, Completed, Sponsor: Sanofi
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change, IO biomarker: Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine (clinicaltrials.gov) - Dec 30, 2012
P1, N=25, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed N=50 --> 25
- Trial completion: Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine (clinicaltrials.gov) - Dec 30, 2012
P1, N=141, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=50 --> 25 Active, not recruiting --> Completed
- Trial completion: Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine (clinicaltrials.gov) - Oct 18, 2012
P1, N=18, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
New P1 trial: DPIV-002: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (clinicaltrials.gov) - Oct 8, 2012
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
- TDENV-PIV / GSK, U.S. Army Medical Research and Development Command
New P1 trial: DPIV-001: A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (clinicaltrials.gov) - Aug 14, 2012
P1, N=100, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
- tetravalent dengue vaccine (TVDV) / Fresh Tracks Therap, U.S. Army Medical Research and Development Command
Enrollment closed: TVDV: Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease (clinicaltrials.gov) - Aug 2, 2012
P1, N=40, Active, not recruiting, Sponsor: U.S. Army Medical Research and Materiel Command
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Trial completion: Study of Febrile Illness for Dengue-Endemic Areas in Latin America (clinicaltrials.gov) - Aug 1, 2012
P=N/A, N=3000, Completed, Sponsor: Sanofi
Recruiting --> Active, not recruiting Active, not recruiting --> Completed